Local calcitriol injections as a suppressive treatment of secondary hyperparathyroidism in chronic dialysis patients.

Aim: A prospective study was made of the effectiveness of repeatable local calcitriol injections therapy to suppress secondary hyperparathyroidism resistant to conventional therapy in chronic dialysis patients.

Methods: Under ultrasonographic guidance, six injections at an interval of two days were performed in 14 chronic dialysis patients. The total amount of calcitriol to be injected each time was estimated as 100% of the calculated gland volume.

[Assessment of plasminogen activator inhibitor-1 and von Willebrand factor as a markers of endothelial function in patients with end-stage kidney disease after allotransplantation during a one-year follow-up].

Objectives: The aim of our study was to determine the endothelial function in patients with chronic kidney disease (CKD), stage V (end-stage renal disease--ESRD), before and during a one-year observation after kidney allotransplantation.

Patients And Methods: We studied 40 patients with stabile graft function after their first kidney transplantation, including 21 females (mean age 41 +/- 12.5 yrs) and 19 males (mean age 43.

[An analysis of microorganisms isolated from blood samples of patients treated at the Department of Nephrology and Internal Diseases].

Unlabelled: The development of invasive medical procedures involves a decrease of prevalence of generalized infections. Hemodialysed patients are at higher risk of infection. The aim of this study was to analyze microorganisms isolated from blood samples of patients treated at the Department of Nephrology and Internal Diseases of the Medical University in Bydgoszcz.

[Seasonal profile of calcium-phosphate metabolism in hemodialysis patients with secondary hyperparathyroidism].

Sunlight UV plays an important role in synthesis of active vitamin D3. Vitamin D3 concentration depends on seasonal sunlight exposure. It was not state, whether these changes may act on secondary hyperparathyroidism (SHP) in hemodialysis (HD) patients.